Clinicopathological features of lung adenocarcinoma with KRAS mutations

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

(2010) Kenichi Suda et al.   CANCER AND METASTASIS REVIEWS

Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue

(2010) Yohei Miyamae et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node Metastasis

(2010) Yoichi Anami et al.   Journal of Thoracic Oncology

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

(2010) Takayuki Kosaka et al.   Journal of Thoracic Oncology

Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon12 Mutations in Lung Adenocarcinoma

(2009) Takuya Araki et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung Cancer

(2009) Howard West et al.   Journal of Thoracic Oncology

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib

(2009) Marie Wislez et al.   LUNG CANCER

Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

(2008) G. J. Riely et al.   CLINICAL CANCER RESEARCH

Rapid Screening Assay for KRAS Mutations by the Modified Smart Amplification Process

(2008) Kenji Tatsumi et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology